Delirium: optimising management

Delirium is a complex neuropsychiatric syndrome with an acute onset and fluctuating course; it is common in all medical settings. Delirium occurs in about 15-20% of all general admissions to hospital1; it occurs with higher frequency in elderly people and in those with pre-existing cognitive impairment.2 Delirium has many synonyms, reflecting its ubiquitous nature rather than distinct conditions. These synonyms include acute brain failure, acute confusional state, and post-operative psychosis. Delirium has not been well studied owing to methodological difficulties and a lack of consensus about its definition. Thus, delirium has been underappreciated as an independent entity that requires therapeutic intervention beyond identification of the syndrome and amelioration of the underlying cause. The development of a clearer definition, improved detection and assessment tools, and recognition of the significant independent morbidity associated with delirium have substantially changed this situation. These developments coupled with a greater awareness of the needs of an increasingly large population of elderly people3 make a review of the day to day management of patients with delirium timely. #### Summary points Delirium is especially common in elderly patients and poses a substantial challenge for clinicians Delirium comprises a wide of range of symptoms, but the prevailing narrow definition impedes diagnosis and efforts to improve treatment Diagnosis can be improved by clinicians becoming more aware of hypoactive presentations, incorporating cognitive assessment into routine practice, and using simple screening instruments Environmental strategies for treatment are free of adverse effects but are underutilised Neuroleptics (such as haloperidol) continue to be used as first line treatment, but benzodiazepines are indicated in specific situations This review is based on the results of a Medline search for articles published between 1980 and 1999 using the key words “delirium,” “acute confusion,” “management,” and “treatment”; as well as hand searching for articles in major journals …

[1]  Y. Okamoto,et al.  Trazodone in the treatment of delirium. , 1999, Journal of clinical psychopharmacology.

[2]  I. Kerr,et al.  Acute disturbed or violent behaviour: principles of treatment , 1997, Journal of psychopharmacology.

[3]  N. Uchimura,et al.  Does plasma free‐3-methoxy‐4-hydroxyphenyl (ethylene) glycol increase in the delirious state? A comparison of the effects of mianserin and haloperidol on delirium , 1997, International clinical psychopharmacology.

[4]  M. Mayo-Smith Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. , 1997, JAMA.

[5]  L. Ganzini,et al.  Misdiagnosing delirium as depression in medically ill elderly patients. , 1995, Archives of internal medicine.

[6]  Jane M. Brokel,et al.  Management of acute delirium in hospitalized elderly: a process improvement project. , 1997, Geriatric nursing.

[7]  S K Inouye,et al.  The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. , 1994, The American journal of medicine.

[8]  T R Holford,et al.  A multicomponent intervention to prevent delirium in hospitalized older patients. , 1999, The New England journal of medicine.

[9]  S. O’Keeffe Clinical Subtypes of Delirium in the Elderly , 1999, Dementia and Geriatric Cognitive Disorders.

[10]  P. Casey,et al.  The Use of Environmental Strategies and Psychotropic Medication in the Management of Delirium , 1996, British Journal of Psychiatry.

[11]  S. Inouye,et al.  Precipitating Factors for Delirium in Hospitalized Elderly Persons: Predictive Model and Interrelationship With Baseline Vulnerability , 1996 .

[12]  P. Pompei,et al.  The natural history of delirium in older hospitalized patients: a syndrome of heterogeneity. , 1997, Age and ageing.

[13]  H. S. Davis,et al.  A Controlled Study , 1966 .

[14]  J. Bostwick,et al.  Psychopharmacological treatment of delirium to restore mental capacity. , 1998, Psychosomatics.

[15]  K. Rockwood,et al.  Increasing the Recognition of Delirium in Elderly Patients , 1994, Journal of the American Geriatrics Society.

[16]  Andrew W. Wood,et al.  A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers , 1999, Journal of psychopharmacology.

[17]  C. Easton,et al.  Sensory-perceptual alterations: delirium in the intensive care unit. , 1988, Heart & lung : the journal of critical care.

[18]  L. Lipsitz,et al.  Progression and Resolution of Delirium in Elderly Patients Hospitalized for Acute Care. , 1994, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[19]  L. Tune,et al.  Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. , 1992, The American journal of psychiatry.

[20]  E. Cassem,et al.  Psychiatric complications in the critically ill cardiac patient. , 1993, Texas Heart Institute journal.

[21]  E. Kunkel,et al.  Pimozide is effective in delirium secondary to hypercalcemia when other neuroleptics fail. , 1993, Psychosomatics.

[22]  D. Fish Treatment of delirium in the critically ill patient. , 1991, Clinical pharmacy.

[23]  B. Wakefield,et al.  Screening for Acute Confusion in Elderly Long‐Term Care Residents , 1997, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

[24]  B. Mulsant,et al.  Is delirium different when it occurs in dementia? A study using the delirium rating scale. , 1998, The Journal of neuropsychiatry and clinical neurosciences.

[25]  M. Cole,et al.  Delirium: Prevention, Treatment, and Outcome Studies , 1998, Journal of geriatric psychiatry and neurology.

[26]  D. Fontaine,et al.  Therapeutic Considerations in the Management of Agitated or Delirious Critically 111 Patients , 1998, Pharmacotherapy.

[27]  K. Khaw How many, how old, how soon? , 1999, BMJ.

[28]  G. Murray,et al.  Decreased extrapyramidal symptoms with intravenous haloperidol. , 1987, The Journal of clinical psychiatry.

[29]  I. Schofield A small exploratory study of the reaction of older people to an episode of delirium. , 1997, Journal of advanced nursing.

[30]  P. Trzepacz Delirium. Advances in diagnosis, pathophysiology, and treatment. , 1996, The Psychiatric clinics of North America.

[31]  W. Breitbart,et al.  A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. , 1996, The American journal of psychiatry.

[32]  G. Murray,et al.  Controlled study of extrapyramidal reactions in the management of delirious, medically ill patients: intravenous haloperidol versus intravenous haloperidol plus benzodiazepines. , 1988, Heart & lung : the journal of critical care.

[33]  P. Jacobsen,et al.  Efficacy of neuroleptics for hypoactive delirium. , 1994, The Journal of neuropsychiatry and clinical neurosciences.

[34]  J. George,et al.  Causes and prognosis of delirium in elderly patients admitted to a district general hospital. , 1997, Age and ageing.

[35]  P. Masand,et al.  Olanzapine in the treatment of delirium. , 1998, Psychosomatics.

[36]  P. Rabbitt,et al.  Long-term postoperative cognitive dysfunction in the elderly: ISPOCD1 study , 1998, The Lancet.

[37]  B. S. Andersson,et al.  Emergency pharmacotherapy of delirium in the critically ill cancer patient. , 1986, Psychosomatics.